ESAB Corporation
ESAB
$115.91
-$3.74-3.13%
Weiss Ratings | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B | |||
Rating Factors | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Good | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.30 | |||
Price History | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -4.33% | |||
30-Day Total Return | -6.70% | |||
60-Day Total Return | -9.12% | |||
90-Day Total Return | -5.73% | |||
Year to Date Total Return | -2.05% | |||
1-Year Total Return | 17.53% | |||
2-Year Total Return | 91.50% | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -14.75% | |||
52-Week Low % Change | 30.92% | |||
Price | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $135.97 | |||
52-Week Low Price | $88.54 | |||
52-Week Low Price (Date) | Aug 02, 2024 | |||
52-Week High Price (Date) | Nov 06, 2024 | |||
Valuation | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 7.02B | |||
Enterprise Value | 7.97B | |||
Price/Earnings (TTM) | 26.87 | |||
Earnings Per Share (TTM) | 4.31 | |||
Earnings Per Share Growth | 28.37% | |||
Price/Earnings To Growth | 0.95 | |||
Price/Sales (TTM) | 2.58 | |||
Price/Book (Q) | 3.97 | |||
Enterprise Value/Revenue (TTM) | 2.91 | |||
Price | $115.91 | |||
Enterprise Value/EBITDA (TTM) | 15.00 | |||
Enterprise Value/EBIT | 17.14 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 61.07M | |||
Dividend Yield | 0.26% | |||
Div. Per Share (Most Recent) | $0.08 | |||
Dividend Per Share (TTM) | $0.30 | |||
Payout Ratio (TTM) | 6.42% | |||
Dividend Per Share (Most Recent) | $0.08 | |||
Company Info | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 301 323 9099 | |||
Address | 909 Rose Avenue North Bethesda, MD 20852 | |||
Website | www.esabcorporation.com | |||
Country | United States | |||
Year Founded | 1904 | |||
Profitability | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 16.95% | |||
Profit Margin | 9.66% | |||
Management Effectiveness | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 7.39% | |||
Return on Equity | 16.96% | |||
Income Statement | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 2.74B | |||
Total Revenue (TTM) | 2.74B | |||
Revenue Per Share | $44.88 | |||
Gross Profit (TTM) | 1.04B | |||
EBITDA (TTM) | 531.41M | |||
EBIT (TTM) | 464.81M | |||
Net Income (TTM) | 264.84M | |||
Net Income Avl. to Common (TTM) | 264.84M | |||
Total Revenue Growth (Q YOY) | -2.70% | |||
Earnings Growth (Q YOY) | 23.55% | |||
EPS Diluted (TTM) | 4.31 | |||
EPS Diluted Growth (Q YOY) | 6.53% | |||
Balance Sheet | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 249.36M | |||
Cash Per Share (Q) | $4.08 | |||
Total Current Assets (Q) | 1.15B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.81B | |||
Current Ratio (Q) | 1.817 | |||
Book Value Per Share (Q) | $29.23 | |||
Total Assets (Q) | 4.03B | |||
Total Current Liabilities (Q) | 632.05M | |||
Total Debt (Q) | 1.16B | |||
Total Liabilities (Q) | 2.23B | |||
Total Common Equity (Q) | 1.77B | |||
Cash Flow | ESAB - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -205.70M | |||
Cash from Financing (TTM) | 31.67M | |||
Net Change in Cash (TTM) | 147.36M | |||
Levered Free Cash Flow (TTM) | 267.31M | |||
Cash from Operations (TTM) | 355.40M | |||